Steinhart Richard I — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Steinhart Richard I has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $12K.

Profile

Richard I. Steinhart is a corporate executive known for his roles as Chief Financial Officer and Director at BioXcel Therapeutics, Inc. and other companies in the biopharmaceutical sector. He has been involved in multiple SEC filings, indicating active participation in corporate governance.

Board memberships

• BioXcel Therapeutics, Inc.
• Actinium Pharmaceuticals, Inc.
• Atossa Therapeutics, Inc.

Awards & honors

• Chief Financial Officer at BioXcel Therapeutics
• Director at multiple biopharmaceutical companies
• Involved in drug development and corporate governance

Recent Transactions

Companies — Last 90 Days

• BioXcel Therapeutics, Inc. (BTAI) — 3 filings, last 2026-06-18
• ATOSSA THERAPEUTICS, INC. (ATOS) — 1 filings, last 2026-05-14

Frequently Asked Questions

Who is Steinhart Richard I?

Richard I. Steinhart is a corporate executive known for his roles as Chief Financial Officer and Director at BioXcel Therapeutics, Inc. and other companies in the biopharmaceutical sector. He has been involved in multiple SEC filings, indicating active participation in corporate governance.…

How many SEC Form 4 filings has Steinhart Richard I submitted recently?

4 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Steinhart Richard I been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 4 open-market sales ($12K) across all tracked filings.

Where can I see all of Steinhart Richard I's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week